公司資料
Evelo Biosciences 股價、新聞與催化劑
- 股票代碼:
- EVLO
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (+9900.00%)
收盤價
最後更新: 2026年9月22日
—
市值
股價為何變動
目前無法取得 EVLO 的收盤價變動背景。
公司概覽
業務概覽
Evelo Biosciences was a biotechnology company that explored oral biologics and immune system modulation before becoming a legacy ticker. Its story was centered on the challenge of turning a novel biology concept into durable human data.
所在地與產業分類
Evelo was headquartered in the United States and listed on NASDAQ. It sat in small-cap biotechnology and immunology.
商業模式特徵
The company depended on translational validation, clinical data, and access to capital. Investors historically watched whether the platform could show enough differentiation to survive in a crowded biotech market.
生技產業定位
Evelo is best viewed as a historical platform-biotech name. Its valuation was always tied to science proof and capital runway more than commercial scale.
未來催化劑
- Evelo Biosciences is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on what value remains.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。